---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264058799.md"
description: "The Nasdaq Biotechnology Index fell by 2.3%. Among the constituent stocks, uniQure NV had the largest decline, reaching 55.76%; Tscan Therapeutics fell by 42.27%; Alvotech dropped by 30.72%; Neurogene decreased by 16.87%. On the other hand, Hutchison China MediTech (HCM) rose by 3.10%, Indivior increased by 4.29%, Acrivon Therapeutics went up by 8.79%, Pyxis Oncology climbed by 11.97%, and Terns Pharmaceuticals surged by 81.84%"
datetime: "2025-11-03T16:04:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264058799.md)
  - [en](https://longbridge.com/en/news/264058799.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264058799.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index fell by 2.3%, with constituent stock uniQure NV currently down 55.76%, Tscan Therapeutics down 42.27%, Alvotech down 30.72%, and Neurogene down 16.87%, the fourth largest decline. Hutchison China MediTech (HCM) rose by 3.10%, ranking fifth, Indivior rose by 4.29%, Acrivon Therapeutics rose by 8.79%, Pyxis Oncology rose by 11.97%, and Terns Pharmaceuticals rose by 81.84%

### Related Stocks

- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)
- [TERN.US](https://longbridge.com/en/quote/TERN.US.md)
- [ACRV.US](https://longbridge.com/en/quote/ACRV.US.md)

## Related News & Research

- [Kevin Warsh Offered a Warning on Inflation. Here's What History Says Is Coming Next.](https://longbridge.com/en/news/303926259.md)
- [Google Says Demand Will Swallow Every Data Center It Builds](https://longbridge.com/en/news/303998103.md)
- [Microsoft Just Revealed a $677 Billion Reason to Buy Its Stock](https://longbridge.com/en/news/303993065.md)
- [Grok Bot Users Hit Unexpected Usage Limits as Musk Cites Rising Costs](https://longbridge.com/en/news/303989157.md)
- [Park Avenue Securities LLC Sells 1,265 Shares of Meta Platforms, Inc. $META](https://longbridge.com/en/news/303952274.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**